Securing domestic earnings and entering overseas markets for medical testing equipment
First written in FY2019. 4 of 5 entries say "Advanced", first in FY2023. Latest entry: FY2026.
The whole theme swung hardest in 2021: 1 of 9 companies on the "Worse" side.
5 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In the Medical Equipment business, the company expects revenue growth from continued launches of new hearing aid products addressing market needs and from further strengthening collaboration with otolaryngology departments. In medical testing equipment, in addition to strengthening sales of newly launched products, the company will reliably identify new domestic clinic-opening projects and convert them into sales.」
For the Medical Equipment business, the company outlined specific measures including launching new products, strengthening collaboration with otolaryngology departments, strengthening sales of new medical testing equipment products, and identifying new domestic clinic-opening projects. - FY2025AdvancedAnnual report
「In medical testing equipment, in addition to launching new products and working to expand sales, we will steadily convert capital investment demand among medical institutions in Japan, particularly otolaryngology departments, into sales.」
For medical testing equipment, the company continues to pursue specific initiatives including launching new products, expanding sales, and converting demand for capital investment by medical institutions, particularly otolaryngology departments, into sales. - FY2024-Q1AdvancedAnnual report
「As capital investment by medical institutions, including customers such as otolaryngology departments, showed signs of recovery, sales of products such as audiometers remained strong, resulting in revenue exceeding that of the same quarter of the previous year,」
For medical testing equipment, the recovery in capital investment by domestic medical institutions translated into higher sales, indicating progress toward securing domestic earnings in the Medical Equipment business. - FY2023AdvancedAnnual report
「In hearing aids, the company aims to expand revenue by enriching its product lineup through new product launches and by strengthening collaboration with otolaryngology departments to increase awareness of its products among people with hearing loss. In medical testing equipment, it will steadily convert demand for capital investment by medical institutions, particularly otolaryngology departments, in the domestic market into sales.」
For the Medical Equipment business, the company outlined specific measures including launching new products, strengthening collaboration with otolaryngology departments, and converting demand for capital investment by medical institutions into sales. - FY2019First statedAnnual report
「The company plans to secure earnings in the domestic market for medical testing equipment and enter overseas markets.」
The company specified, for the first time, securing earnings in the domestic market and entering overseas markets for medical testing equipment as initiatives.